Satellos Bioscience Inc. , a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders, today announced a late-breaking.
Beyond Surgery: MTF Biologics Invests in Science to Transform Lives biharprabha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biharprabha.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ REGENXBIO Inc. (Nasdaq: RGNX) today announced presentations at the American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meeting, taking.
Ryan Mitchell, PhD and Director of Business Development at Satellos to highlight SAT-3153 and Satellos' novel muscle regeneration technology in two forums at this year's MDA Conference and Summit
Toronto